Deutsche Bank’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.17M | Buy |
353,552
+378
| +0.1% | +$5.6K | ﹤0.01% | 1353 |
|
|
2026
Q1 | $5.12M | Buy |
353,174
+271,884
| +334% | +$3.16M | ﹤0.01% | 1286 |
|
|
2025
Q4 | $781K | Hold |
81,290
| – | – | ﹤0.01% | 2329 |
|
|
2025
Q3 | $764K | Hold |
81,290
| – | – | ﹤0.01% | 2318 |
|
|
2025
Q2 | $860K | Sell |
81,290
-3,969
| -5% | -$50.1K | ﹤0.01% | 2176 |
|
|
2025
Q1 | $1.28M | Buy |
85,259
+10,760
| +14% | +$179K | ﹤0.01% | 2020 |
|
|
2024
Q4 | $1.23M | Sell |
74,499
-11,805
| -14% | -$233K | ﹤0.01% | 2134 |
|
|
2024
Q3 | $2.13M | Buy |
86,304
+3,686
| +4% | +$95.6K | ﹤0.01% | 1699 |
|
|
2024
Q2 | $2.09M | Sell |
82,618
-208
| -0.3% | -$5.39K | ﹤0.01% | 1616 |
|
|
2024
Q1 | $2.1M | Buy |
82,826
+770
| +0.9% | +$18.6K | ﹤0.01% | 1637 |
|
|
2023
Q4 | $1.86M | Buy |
82,056
+74,139
| +936% | +$1.53M | ﹤0.01% | 1716 |
|
|
2023
Q3 | $147K | Sell |
7,917
-73,025
| -90% | -$1.51M | ﹤0.01% | 2968 |
|
|
2023
Q2 | $2.1M | Buy |
80,942
+45,148
| +126% | +$1.21M | ﹤0.01% | 1594 |
|
|
2023
Q1 | $1.03M | Buy |
35,794
+2,927
| +9% | +$87.1K | ﹤0.01% | 2083 |
|
|
2022
Q4 | $973K | Buy |
32,867
+126
| +0.4% | +$3.58K | ﹤0.01% | 2072 |
|
|
2022
Q3 | $780K | Sell |
32,741
-853
| -3% | -$19.6K | ﹤0.01% | 2119 |
|
|
2022
Q2 | $750K | Sell |
33,594
-960
| -3% | -$21.4K | ﹤0.01% | 2351 |
|
|
2022
Q1 | $868K | Sell |
34,554
-940
| -3% | -$28.7K | ﹤0.01% | 2440 |
|
|
2021
Q4 | $1.27M | Sell |
35,494
-133
| -0.4% | -$5.32K | ﹤0.01% | 2287 |
|
|
2021
Q3 | $1.52M | Buy |
35,627
+237
| +0.7% | +$9.76K | ﹤0.01% | 2324 |
|
|
2021
Q2 | $1.53M | Buy |
35,390
+18,831
| +114% | +$802K | ﹤0.01% | 2465 |
|
|
2021
Q1 | $675K | Buy |
16,559
+6,662
| +67% | +$253K | ﹤0.01% | 2902 |
|
|
2020
Q4 | $448K | Sell |
9,897
-3,165
| -24% | -$120K | ﹤0.01% | 2981 |
|
|
2020
Q3 | $462K | Sell |
13,062
-85,632
| -87% | -$3.09M | ﹤0.01% | 2679 |
|
|
2020
Q2 | $3.72M | Sell |
98,694
-5,431
| -5% | -$179K | ﹤0.01% | 1460 |
|
|
2020
Q1 | $3.01M | Sell |
104,125
-17,875
| -15% | -$723K | ﹤0.01% | 1494 |
|
|
2019
Q4 | $6.32M | Buy |
122,000
+111,804
| +1,097% | +$6.49M | ﹤0.01% | 1316 |
|
|
2019
Q3 | $558K | Sell |
10,196
-29,683
| -74% | -$1.52M | ﹤0.01% | 2624 |
|
|
2019
Q2 | $1.62M | Sell |
39,879
-75,687
| -65% | -$2.76M | ﹤0.01% | 2539 |
|
|
2019
Q1 | $3.49M | Buy |
115,566
+13,517
| +13% | +$463K | ﹤0.01% | 2104 |
|
|
2018
Q4 | $3.43M | Sell |
102,049
-192,056
| -65% | -$6.93M | ﹤0.01% | 2046 |
|
|
2018
Q3 | $12.4M | Sell |
294,105
-77,082
| -21% | -$3.05M | 0.01% | 1470 |
|
|
2018
Q2 | $11.9M | Buy |
371,187
+235,803
| +174% | +$9.71M | 0.01% | 1603 |
|
|
2018
Q1 | $6.73M | Buy |
135,384
+44,800
| +49% | +$2.53M | ﹤0.01% | 1961 |
|
|
2017
Q4 | $4.88M | Buy |
90,584
+21,906
| +32% | +$1.21M | ﹤0.01% | 2049 |
|
|
2017
Q3 | $3.98M | Buy |
68,678
+5,202
| +8% | +$272K | ﹤0.01% | 2059 |
|
|
2017
Q2 | $3.13M | Sell |
63,476
-12,959
| -17% | -$597K | ﹤0.01% | 2259 |
|
|
2017
Q1 | $3.32M | Buy |
76,435
+18,398
| +32% | +$878K | ﹤0.01% | 1925 |
|
|
2016
Q4 | $2.84M | Sell |
58,037
-30,466
| -34% | -$1.41M | ﹤0.01% | 2031 |
|
|
2016
Q3 | $4.23M | Sell |
88,503
-29,292
| -25% | -$1.45M | ﹤0.01% | 1851 |
|
|
2016
Q2 | $6.32M | Buy |
117,795
+35,337
| +43% | +$1.66M | ﹤0.01% | 1588 |
|
|
2016
Q1 | $3.69M | Buy |
82,458
+40,537
| +97% | +$1.64M | ﹤0.01% | 1957 |
|
|
2015
Q4 | $1.6M | Sell |
41,921
-5,145
| -11% | -$197K | ﹤0.01% | 2597 |
|
|
2015
Q3 | $1.5M | Sell |
47,066
-9,059
| -16% | -$316K | ﹤0.01% | 2676 |
|
|
2015
Q2 | $1.85M | Buy |
56,125
+16,184
| +41% | +$577K | ﹤0.01% | 2509 |
|
|
2015
Q1 | $1.64M | Sell |
39,941
-16,726
| -30% | -$676K | ﹤0.01% | 2576 |
|
|
2014
Q4 | $2.31M | Buy |
56,667
+24,626
| +77% | +$963K | ﹤0.01% | 2562 |
|
|
2014
Q3 | $1.17M | Sell |
32,041
-38,775
| -55% | -$1.68M | ﹤0.01% | 2910 |
|
|
2014
Q2 | $3.28M | Sell |
70,816
-16,510
| -19% | -$734K | ﹤0.01% | 2130 |
|
|
2014
Q1 | $3.59M | Buy |
87,326
+71,422
| +449% | +$2.65M | ﹤0.01% | 2044 |
|
|
2013
Q4 | $606K | Buy |
15,904
+1,598
| +11% | +$49.3K | ﹤0.01% | 2967 |
|
|
2013
Q3 | $341K | Buy |
14,306
+4,947
| +53% | +$111K | ﹤0.01% | 3772 |
|
|
2013
Q2 | $158K | Buy |
+9,359
| New | +$135K | ﹤0.01% | 3969 |
|
Other funds holding ANIK
CM
IP
CWP
RS
Deutsche Bank's ANIK Position: Q2 2026 in Review
Deutsche Bank increased its Anika Therapeutics (ANIK) stake by 0.11% in Q2 2026, buying an estimated $5.6K and bringing the position to 353,552 shares worth $5.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1353.
Deutsche Bank first reported a position in ANIK in Q2 2013 and has held it in 53 quarters since. The position peaked at $12.4M in Q3 2018. 43 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.
- Deutsche Bank held 353,552 shares of Anika Therapeutics worth $5.17M as of Q2 2026.
- Deutsche Bank bought 378 Anika Therapeutics shares in Q2 2026, an estimated $5.6K.
- Anika Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1353 holding.
- Deutsche Bank first reported a position in Anika Therapeutics in Q2 2013 and has held it in 53 quarters since.
- Deutsche Bank's Anika Therapeutics position peaked at $12.4M in Q3 2018.
- 43 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.
Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.